Follow Us:
Changing Paradigms in the Diagnosis and Treatment of Multiple Myeloma
These webcasts are co-provided by the CancerNet and A. Webb Roberts Center for CME of Baylor Scott & White Health.
For more information visit: www.cancernetus.com
 |
 |
Amgen, Inc.
These webcasts are intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussions of novel agents at various stages of clinical development will be given significant focus. These Internet CME activities are designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Each module offers:
- 1.25 to 1.5 AMA PRA Category 1 Credits™ for physicians, per module
Module 1
This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Module 2
This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Module 3
This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.